Search Results 791-800 of 17025 for pharmacogenetics
The primary purpose of this study is to assess progression-free survival of men who have oligometastatic prostate cancer after randomization to stereotactic ...
About this study. The primary objective of this program is to provide Daclatasvir (DCV) for 24 weeks to be given in combination with Sofosbuvir (SOF) to ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Nicotine patches and behavioral therapy may help reduce cigarette smoking and binge drinking in young adults.This randomized clinical trial studies nicotine ...
About this study. The purpose of this study is to assess operative and postoperative outcomes after aortic valve surgery, evaluate for changes in ascending ...
This randomized pilot trial studies whether auranofin will relieve pain following paclitaxel in patients who have previously experienced paclitaxel-induced pain ...
A secondary aim will be to record what specific interventions are utilized by the CCLS during vaccine administration and its relation to patient-reported pain ...
This is a prospective, multi-center, non-randomized clinical evaluation utilizing the PulseRider® Aneurysm Neck Reconstruction Device. Participation eligibility.
Regenerative Medicine Minnesota (RMM) has awarded funding to 10 high-impact projects aimed at accelerating the development of breakthrough therapies that ...
A Study of JNJ-63723283, an Anti-programmed Death-1 Monoclonal Antibody, Administered in Combination With Daratumumab, Compared With Daratumumab Alone in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!